T. Rowe Price Associates’s Astera Labs ALAB Stock Holding History

T. Rowe Price Associates’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.8M	Sell	618,499 -545,915	-47%	-$77.8M	0.01%	703
2025 Q4	$194M	Buy	1,164,414 +720,844	+163%	+$121M	0.02%	474
2025 Q3	$86.9M	Buy	443,570 +386,161	+673%	+$63.5M	0.01%	654
2025 Q2	$5.19M	Buy	57,409 +14,270	+33%	+$1.13M	﹤0.01%	1259
2025 Q1	$2.58M	Sell	43,139 -179,780	-81%	-$16.6M	﹤0.01%	1499
2024 Q4	$29.5M	Buy	222,919 +208,971	+1,498%	+$19.6M	﹤0.01%	896
2024 Q3	$731K	Sell	13,948 -200,538	-93%	-$9.41M	﹤0.01%	2096
2024 Q2	$13M	Sell	214,486 -385,514	-64%	-$26.7M	﹤0.01%	1057
2024 Q1	$44.5M	Buy	+600,000	New	+$44.5M	0.01%	762

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

T. Rowe Price Associates's ALAB Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Astera Labs (ALAB) stake by 47% in Q1 2026, selling an estimated $77.8M and leaving 618,499 shares worth $67.8M. The position accounts for 0.01% of the portfolio, ranked #703.

T. Rowe Price Associates first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $194M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

T. Rowe Price Associates held 618,499 shares of Astera Labs worth $67.8M as of Q1 2026.
T. Rowe Price Associates sold 545,915 Astera Labs shares in Q1 2026, an estimated $77.8M.
Astera Labs made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #703 holding.
T. Rowe Price Associates first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
T. Rowe Price Associates's Astera Labs position peaked at $194M in Q4 2025.
703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.